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Domain swapped protein dimers consist of a swapped domain linked by a hinge
loop. They have been proposed as a means of achieving larger assemblies
potentially contributing to biological cellular activity or conferring disease.
Here we present a crystal structure of a C-terminal domain swapped dimer in
yeast iso-1-cytochrome c. In this structure the C-terminal alpha helix from
one monomer positions itself in the native position of the opposite monomer
and vice versa. The highly dynamic heme crevice loop, the most highly
conserved portion of the cytochrome c sequence, spans the gap acting as the
hinge loop. Interestingly, conversion of the heme crevice loop to the hinge
loop results in a loss of the native Met80-heme ligation. This produces an
open heme coordination site on each subunit of the dimer. As cytochrome c re-
quires an open heme coordination site to act as a peroxidase, to oxidize cardi-
olipin and initiate the intrinsic apoptotic pathway, this dimer structure could
potentially be a structure particularly suited to function in oxidizing cardiolipin.
In fact, a recently reported C-terminal domain swapped dimer of horse cyto-
chrome c demonstrates increased peroxidase activity relative to the monomer.
Although the yeast and horse dimer are similar, the hinge loop orientations
differ. The hinge loop is two residues longer in the yeast dimer resulting in
an increased distance between the heme groups and an altered angle of the
hinge loops relative to the horse cytochrome c dimer. Even though they contain
similar structure and sequence, the domain swapped yeast iso-1-cytochrome c
dimer demonstrates decreased stability compared to the horse cytochrome c
dimer.
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GlbN, the ‘‘truncated’’ hemoglobin from Synechocystis sp. PCC 6803, coordi-
nates the heme iron with His46 (E10, distal) and His70 (F8, proximal).
Displacement of His E10 by an exogenous ligand (e.g., cyanide in the ferric
state) drives a significant conformational change allowing Tyr22 (B10),
Gln43 (E7) and Gln47 (E11) to establish a hydrogen bond network stabilizing
the distal ligand.
THB1, a closely related hemoglobin from Chlamydomonas reinhardtii, also
binds cyanide and forms the same network of interactions. However, in the
absence of an exogenous ligand, the neutral amino group of Lys53 (E10)
coordinates the heme iron on the distal side [1]. Because of the importance
of the coordination scheme in controlling the reactivity of heme proteins,
the flexibility of the truncated hemoglobin fold, and the rarity of lysine coor-
dination, we explored the ability of GlbN to use lysine at position E10 as an
axial ligand. The His46Lys replacement yielded a protein with UV-Vis and
NMR spectra similar to those of His46Leu and comparable pH response, sug-
gesting that GlbN does not accommodate lysine coordination at position E10.
However, the spectra were incompatible with water coordination and sug-
gested that in the ferric state these variants were low-spin endogenously hex-
acoordinate complexes. We performed amino acid replacements within the
distal H-bond network to characterize the perturbed heme environment and
ligand sets. A combination of pH titrations and NMR experiments illustrates
the delicate balance of interactions governing the heme pocket conformation
of GlbN.
[1] Johnson et al. (2014) Biochemistry 53:4573
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The inhibition of the first calcium and integrin binding protein, CIB1 has been
observed to interfere with signaling in breast-cancer cells by inducing non-
apoptotic cancer cell death without harming healthy cells. This has led to a
push for creating targeted therapy drugs which inhibit the CIB1 protein. While
inhibiting CIB1 kills cancer cells, inhibiting the second protein, CIB2, could
lead to hearing loss or deafness. Since CIB2 and CIB1 share similar sequences,I wanted to determine whether CIB2 could be inhibited by the potential targeted
therapy drugs used to inhibit CIB1. Since no structure for CIB2 exists, I first
created a homology model for the protein by threading the sequence for
CIB2 onto the 2LM5 PDB structure of CIB1. This model was relaxed using
Discrete Molecular Dynamics and analyzed for stability. Maestro and Peptide
Docking simulations were then used to examine the model for druggable sites
and association sites. The druggable sites were used for virtual screening with
MedusaDock, where the results for CIB2 were to be compared to a previous
virtual screening done for CIB1. Any drugs that were found to bind to both pro-
teins would be excluded as targeted therapy candidates. By analyzing the model
I was able to determine that CIB2 has one bipartite druggable site and two pep-
tide association sites. Since the peptide association sites and druggable site on
CIB2 were different in location and composition to the peptide and druggable
site on CIB1, I concluded that the targeted therapy drugs created for CIB1 will
have no effect on the functioning of CIB2. In the future, my lab intends to deter-
mine which association site on CIB2 corresponds to the actual peptide-binding
site, as well as analyze the virtual screening results and experimentally validate
the data from our simulations.
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Cardiac Troponin C (TnC) is a Ca2þ-binding protein and plays an important
role in regulation of muscle contraction. Mutations in cTnC are implicated
in phenotypic characteristics known as hypertrophic and dilated cardiomyop-
athy (HCM and DCM, respectively). However, the structural mechanisms un-
derlying cardiac dysfunction are unknown. The main goal of this work is to
investigate changes in stability and dynamics of seven cTnC variants (A8V,
D145E, C84Y and A31S related to HCM; and Y5H, M103I and I148V
related to DCM) using an ensemble of thermodynamic and structural ap-
proaches. Ca2þ-titrations monitored by bis-ANS fluorescence revealed that
D145E, A31S and all mutations related with DCM decreased the Ca2þ-
induced hydrophobic exposure, while C84Y substantially enhance it by the
N-domain exposure compared to WT. Thermostability monitored by circular
dichroism revealed similar melting temperatures between apo and holo states
for D145E (apo: 66.4 5 1.4C, holo: 65.4 5 1.6C) but different values for
WT (apo: 655 1.9C and holo: >90C) and C84Y (apo: 43.85 1.5C, holo:
66.6 5 0.8C). Shape restorations from small angle X-ray scattering were
used to evaluate conformational changes induced by the mutations. In
the apo state, an increase in the radius of gyration values upon increasing
concentrations of urea was observed for the Y5H, A31S, M103I and I148V
mutants compared to WT. Furthermore, the D145E displayed the most
affected shape compared to WT and perturbed residues were located at the
C-domain as confirmed by chemical shift perturbation analysis. In addition,
the D145E secondary structure was not significantly altered by dihedral
angles prediction from the NMR assignment data. These observations open
up new avenues for the comprehension of the complex behavior of HCM
and DCM mutations in cTnC that has heretofore been not evaluated at struc-
tural level.
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Methionine oxidation introduces methionine-aromatic interactions that play a
significant role in secondary structure conformation and stabilization. Calmod-
ulin (CaM) contains nine methionine residues that function as targets of revers-
ible oxidation, serving as a mechanism through which the cell senses and
responds to oxidative stress. Replica exchange molecular dynamics (REMD)
simulations illustrated that methionine oxidatin of the N-terminal helix of
CaM introduces two configurations that involve oxidized methionines at posi-
tions 144 and 145 interacting with tyrosine 138. As these configurations do not
occur in the unoxidized helix, we propose the conformational change is induced
by the stabilizing methionine-aromatic interaction. To verify the effect, elec-
tron paramagnetic resonance (EPR) spectroscopy performed with CaM at sub-
micromolar [Ca2þ] with probes near the residues of interest revealed two
populations in the oxidized sample and only one in the unoxidized sample,
